News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amilpar: Relevant Fact - 3rd Issuance of Common Debentures


9/27/2010 8:53:54 AM

RIO DE JANEIRO, Sept. 24 /PRNewswire/ -- Amil Participacoes S.A. ("Amilpar"), in accordance with CVM Instruction 358, of January 3, 2002, informs that its Board of Directors approved today the 3rd Issuance of Common Debentures, not convertible into shares, with Floating Guarantee, up to four series, for public distribution, with restricted selling efforts ("Debentures") from Amilpar ("Restricted Offering" and "Issuance", respectively), according to CVM Instruction 476/09. Up to 900,000 (nine hundred thousand) Debentures will be issued, with a unit nominal value of R$ 1,000.00 (one thousand reais). The total amount of the issuance will be up to R$ 900,000,000.00 (nine hundred million reais).

The issuance will be made through up to 4 (four) series, in accordance with paragraph 3, article 59 of Brazilian Corporate Law. The Debentures of each series will have the following expiration dates: (a) 1st series: 3 (three) years from its issuance date, expiring on October 15, 2013; (b) 2nd series: 4 (four) years from its issuance date, expiring on October 15, 2014; (c) 3rd series: 5 (five) years from its issuance date, expiring on October 15, 2015; (d) 4th series: 5 (five) years from its issuance date, expiring on October 15, 2015.

The remuneration of the Debentures of 1st, 2nd, and 3rd series will be calculated exponentially and cumulatively, pro rata temporis, by elapsed work days, incident on the unit nominal value or the balance of the nominal value, since the issuance date or the date of payment of the respectively prior remuneration, as appropriate, until the respective expiration date, and paid at the end of each capitalization period.

The Offering aims exclusively qualified investors, according to items I and II, article 4, of CVM Instruction 476 and the public distribution registration in CVM is automatically exempt, pursuant to CVM Instruction 476.

Fitch attributed the rating AA- (bra) to the Offering, aligned with Amilpar's corporate rating.

To access the .pdf full version of the document visit our website at www.amilpar.com.br/ir

IR Contact

Erwin Kleuser

Investor Relations Officer

Phone: +55 (21) 3805-1155

invest@amil.com.br

www.amilpar.com.br/ir



About Amilpar

Amil Participacoes S.A. is the largest healthcare company in Brazil, according to the ANS, currently assisting over 5 million members in the states of Sao Paulo, Rio de Janeiro, ParanĂ¡, Minas Gerais, Pernambuco, Bahia and in Distrito Federal.

SOURCE Amilpar


Read at BioSpace.com

comments powered by Disqus
Amilpar
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES